Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients ≥ 18 years of age~* An acute onset of at least 3 of the following signs and symptoms (new or worsening):~  1. Cough~ 2. Production of purulent sputum~ 3. Shortness of breath (dyspnea)~ 4. Chest pain due to pneumonia~* At least 1 of the following:~  1. Fever~ 2. Hypothermia~ 3. Presence of pulmonary rales and/or evidence of pulmonary consolidation~* PORT Risk Class II, III, or IV~* Presence of lobar, multilobar, or patchy parenchymal infiltrate(s) consistent with acute bacterial pneumonia on a pulmonary imaging study~* Not received any systemic antibiotics during the prior 7 days~Exclusion Criteria:~* Ventilator-associated pneumonia~* Known anatomical or pathological bronchial obstruction or a history of bronchiectasis or documented severe chronic obstructive pulmonary disease~* Hospitalization within 90 days or residence in a long-term care facility within 30 days prior to the onset of symptoms~* Fungal pneumonia~* Pneumocystis jiroveci pneumonia~* Aspiration pneumonia~* Other non-infectious causes of pulmonary infiltrates~* Primary or metastatic lung cancer~* Cystic fibrosis~* Active or suspected tuberculosis~* HIV or myasthenia gravis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Moxifloxacin (Type: ACTIVE_COMPARATOR): Intravenous with the potential step-down to oral moxifloxacin
- Solithromycin (Type: EXPERIMENTAL): Intravenous with potential step-down to oral solithromycin

Based on this trial design, predict the completion outcome and termination type (if applicable).